As I reflect on the past year here at Tilray, I am incredibly proud of what we have accomplished as a company. Tilray has an ambitious goal of becoming the world’s most trusted and valued cannabis and hemp company, and we are well on our way to achieving it. From expanding our Tilray family with the acquisition of Smith & Sinclair and Manitoba Harvest to officially opening the doors of our EU campus in Portugal, we’ve made tremendous strides to secure our place at the forefront of this industry.



As early leaders in the emerging global cannabis and hemp market, we have maintained our position as pioneers through the many groundbreaking accomplishments of the past year. Today, our global production footprint sits at 3.4 million square feet worldwide, and we continue to support clinical trials in Canada, Australia and the United States to help advance cannabinoid research. With each achievement, I’m encouraged to know we remained committed to our mission this year, improving the lives of our patients and consumers around the world through cannabis and hemp.



I’m grateful to our dedicated team at Tilray, our visionary investors, our valued stakeholders and other supporters whose commitment to our collective success has been incredible to witness. We have navigated this rapidly growing and shifting industry with great tenacity in pursuit of our ambitious goals.



As we positively transform the narrative around cannabis and end the harms caused by prohibition, I maintain that we are still in the early days of this industry. There is more work yet to be done, and I couldn’t be more excited for what’s next.



Wishing you and your loved ones an exciting and happy New Year filled with joy and endless possibilities.



Sincerely,

Brendan Kennedy

Tilray CEO